Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher P Fox

Showing results (11-20 of 127) with videos related to

Pageof 13
Sort By:
The Lancet. Haematology|May 30, 2020
Survival outcomes for extranodal natural-killer T-cell lymphoma - Authors' replyChristopher P Fox, Monica Civallero, Massimo Federico, et al.
BMJ Case Reports|June 2, 2019
Paraneoplastic erythroderma: unusual presentation secondary to diffuse large B cell lymphomaPuo Nen Lim, Christopher P Fox, Manjula Pammi, et al.
Lancet (London, England)|October 18, 2025
Glofitamab with GemOx for diffuse large B-cell lymphoma - Authors' replyJeremy S Abramson, Matthew Ku, Gareth P Gregory, et al.
Drug News & Perspectives|June 4, 2010
Immunotherapy for Epstein-Barr virus-associated malignanciesHeather M Long, Gregory Parsonage, Christopher P Fox, et al.
British Journal of Haematology|May 13, 2014
Follicular helper T-cells: expanding roles in T-cell lymphoma and targets for treatmentMatthew J Ahearne, Rebecca L Allchin, Christopher P Fox, et al.
Hematological Oncology|May 18, 2026
Incidence and Survival of Patients With Angioimmunoblastic T-Cell Lymphoma: A Nationwide Population-Based Study Using English Cancer Registration DataSarah J Halligan, Christopher P Fox, Matthew J Grainge, et al.
Ejhaem|July 3, 2026
MRI Predictors of Outcome in Primary Central Nervous System Lymphoma Patients Before and After Autologous Stem Cell TransplantDewen Meng, Hamza Alshuft, Christopher P Fox, et al.
British Journal of Haematology|April 11, 2016
Idelalisib-Rituximab induces clinical remissions in patients with TP53 disrupted B cell prolymphocytic leukaemiaToby A Eyre, Christopher P Fox, Paneesha Shankara, et al.
Health Science Reports|January 8, 2024
A Delphi study to determine the epidemiology and clinical management of patients treated with HDMTX who develop methotrexate (MTX) delayed elimination in France, Germany, Italy, and the UKStefan Bielack, Christopher P Fox, Khê Hoang-Xuan, et al.
British Journal of Haematology|May 21, 2020
The prevention of central nervous system relapse in diffuse large B-cell lymphoma: a British Society for Haematology good practice paperPamela McKay, Matthew R Wilson, Sridhar Chaganti, et al.
Pageof 13

Showing results (11-20 of 127) with videos related to

Sort By:
Pageof 13
The Lancet. Haematology|May 30, 2020
Survival outcomes for extranodal natural-killer T-cell lymphoma - Authors' replyChristopher P Fox, Monica Civallero, Massimo Federico, et al.
BMJ Case Reports|June 2, 2019
Paraneoplastic erythroderma: unusual presentation secondary to diffuse large B cell lymphomaPuo Nen Lim, Christopher P Fox, Manjula Pammi, et al.
Lancet (London, England)|October 18, 2025
Glofitamab with GemOx for diffuse large B-cell lymphoma - Authors' replyJeremy S Abramson, Matthew Ku, Gareth P Gregory, et al.
Drug News & Perspectives|June 4, 2010
Immunotherapy for Epstein-Barr virus-associated malignanciesHeather M Long, Gregory Parsonage, Christopher P Fox, et al.
British Journal of Haematology|May 13, 2014
Follicular helper T-cells: expanding roles in T-cell lymphoma and targets for treatmentMatthew J Ahearne, Rebecca L Allchin, Christopher P Fox, et al.
Hematological Oncology|May 18, 2026
Incidence and Survival of Patients With Angioimmunoblastic T-Cell Lymphoma: A Nationwide Population-Based Study Using English Cancer Registration DataSarah J Halligan, Christopher P Fox, Matthew J Grainge, et al.
Ejhaem|July 3, 2026
MRI Predictors of Outcome in Primary Central Nervous System Lymphoma Patients Before and After Autologous Stem Cell TransplantDewen Meng, Hamza Alshuft, Christopher P Fox, et al.
British Journal of Haematology|April 11, 2016
Idelalisib-Rituximab induces clinical remissions in patients with TP53 disrupted B cell prolymphocytic leukaemiaToby A Eyre, Christopher P Fox, Paneesha Shankara, et al.
Health Science Reports|January 8, 2024
A Delphi study to determine the epidemiology and clinical management of patients treated with HDMTX who develop methotrexate (MTX) delayed elimination in France, Germany, Italy, and the UKStefan Bielack, Christopher P Fox, Khê Hoang-Xuan, et al.
British Journal of Haematology|May 21, 2020
The prevention of central nervous system relapse in diffuse large B-cell lymphoma: a British Society for Haematology good practice paperPamela McKay, Matthew R Wilson, Sridhar Chaganti, et al.
Pageof 13